Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

127 in total

1. Hepatic Resection Improves Long-Term Survival of Patients with Large and/or Multinodular Hepatocellular Carcinoma.

Authors: Ling Deng; Chun Yang; Le-Qun Li; Jian-Hong Zhong
Journal: J Gastrointest Surg Date: 2015-10-13 Impact factor: 3.452

2. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.

Authors: Hao-Long Qi; Chang-Sheng Li; Chong-Wei Qian; Yu-Sha Xiao; Yu-Feng Yuan; Quan-Yan Liu; Zhi-Su Liu
Journal: Tumour Biol Date: 2015-08-14

3. Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?

Authors: Chuan Chen; Dong-Ping Chen; Yan-Yan Gu; Liang-Hao Hu; Dan Wang; Jin-Huan Lin; Zhao-Shen Li; Jing Xu; Ge Wang
Journal: Tumour Biol Date: 2015-04-02

Review 4. Peri-operative use of sorafenib in liver transplantation: a time-to-event meta-analysis.

Authors: Hao-Long Qi; Bing-Jie Zhuang; Chang-Sheng Li; Quan-Yan Liu
Journal: World J Gastroenterol Date: 2015-02-07 Impact factor: 5.742

5. Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations.

Authors: A Ruth He; Alec S Goldenberg
Journal: Therap Adv Gastroenterol Date: 2013-11 Impact factor: 4.409

6. Multi-omics in prognosis of hepatocellular carcinoma.

Authors: Anna Lena Ress; Rishi Wagle; Martin Pichler
Journal: Ann Transl Med Date: 2015-01

7. What are the options for hepatocellular carcinoma patients who progress under sorafenib?

Authors: Eunice Y-T Lau; Terence K-W Lee
Journal: Hepat Oncol Date: 2016-03-23

Review 8. RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma.

Authors: Riccardo Lencioni; Dania Cioni
Journal: Hepat Oncol Date: 2016-06-10

Review 9. Treatment of intermediate-stage hepatocellular carcinoma.

Authors: Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal: Nat Rev Clin Oncol Date: 2014-08-05 Impact factor: 66.675

10. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.

Authors: Omar Abdel-Rahman; Winson Y Cheung
Journal: Med Oncol Date: 2019-02-01 Impact factor: 3.064